
    
      -  Quality assurance plan for data validation and registry: After Data was registered, it
           was reviewed by a second person who compared it to the Data in patient data collection
           forms.

        -  Data check: carried out using Statistical Package for the Social Sciences (SPSS)
           variable definition protocols. Also data were entered in EXCEL sheets for comparisons to
           guarantee consistency.

        -  Source data verification: Paper case report forms and medical records.

        -  Standard Operating Procedures to address registry operations and analysis activities:
           Eligible patients were recruited after obtaining consent. Data was collected by
           qualified personnel rained on the process. Data was entered into Excel sheets and SPSS
           programs and compared for consistency. Analysis of Data was carried out by a qualified
           statistician. Adverse events were reported as yes/no variables. Data of patients who had
           Change in management was omitted from analysis.

        -  Sample size assessment: Sample size was calculated to detect a 65% reduction in the
           analgesic requirement during the first 24 h from 75% in the bupivacaine group with α=
           0.05 and β=0.80.

        -  Plan for missing data: Patients with missing Data were omitted from statistical
           analysis.

        -  Statistical analysis plan: carried out using International Business Machines (IBM)
           statistics 19.0 statistical package for windows. Data were compared using analysis of
           variance for continuous variables, Kruskal-Wallis test for ordinal, and chi square test
           for categorical ones. Post hoc analyses were carried out as appropriate.
    
  